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Few animal models of
whole-brain irradiation take
into account young age and
dose fractionation. We pre-
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long-term cognitive deficits and morbidity develop that are poorly understood and
for which there is no treatment. We describe similar cognitive defects in juvenile
WBI rats and correlate them with alterations in diffusion tensor imaging and magnetic
resonance spectroscopy (MRS) during brain development.
Methods and Materials: Juvenile Fischer rats received clinically relevant fractionated
doses of WBI or a high-dose exposure. Diffusion tensor imaging and MRS were per-
formed at the time of WBI and during the subacute (3-month) and late (6-month)
phases, before behavioral testing.
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of pediatric brain tumors
including development of
early prefrontal dysfunction
and late memory deficits that
correlate with developmental
imaging abnormalities.subacute response, but thereafter there was no further increase in fractional anisotropy,
especially in the high-dose group. Similarly, the ratios of various MRS metabolites to
creatine increased over the study period, and in general, the most significant changes
after WBI were during the late phase and with the higher dose. The most dramatic
changes observed were in glutamine-creatine ratios that failed to increase normally be-
tween 3 and 6 months after either radiation dose. WBI did not affect the ambulatory
response to novel open field testing in the subacute phase, but locomotor habituation
was impaired and anxiety-like behaviors increased. As for cognitive measures, the
most dramatic impairments were in novel object recognition late after either dose
of WBI.
Conclusions: The developing brains of juvenile rats given clinically relevant fraction-
ated doses of WBI show few abnormalities in the subacute phase but marked late
cognitive alterations that may be linked with perturbed MRS signals measured in
the corpus callosum. This pathomimetic phenotype of clinically relevant cranial irra-
diation effects may be useful for modeling, mechanistic evaluations, and testing of
mitigation approaches.  2016 The Author(s). Published by Elsevier Inc. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Whole-brain irradiation (WBI) for children with cancer
leads to profound lifelong morbidity and early death (1),
including endocrinopathies (2), cerebrovascular disease
(3), and advanced brain aging (4), leading to progressive
declines in IQ (5-7), decreased academic achievement
(8), reduced earning potential, and poorer quality of life
(9). Because approximately one-quarter of all pediatric
patients who have received cranial irradiation now sur-
vive, assessing radiation-induced damage to the devel-
oping brain is critical for treatment and planning
strategies (10). Known risk factors include age at treat-
ment (1, 11, 12) and radiation dose (6). Conformal ra-
diation treatment planning (13, 14) and particle radiation
therapy (15) may reduce the total hippocampal dose but
are of limited value where extensive areas of the brain
have to be treated (16).
Animal models demonstrate several potential mecha-
nisms of injury after WBI, including cerebrovasculature
injury (17, 18), loss of neuronal progenitors (19, 20), white
matter injury (21, 22), and persistent inflammation (23).
Responses evolve over time, with most serious symptoms
being expressed during the subacute and late phases, which
may have different pathologic mechanisms (23); the latter
are considered irreversible. Little is known about how the
developing brain responds to clinical fractionated WBI,
with most data coming from animal models using adults
and single dose fractions, which may mislead (24, 25).
In this study we follow imaging and cognitive subacute
and late responses in the developing brains of juvenile
rats to a clinically relevant course of fractionated WBI
similar to what is used to treat children with high-risk
medulloblastoma.Methods and Materials
All studies were approved by the Institutional Animal Care
and Use Committee and performed in accordance with
federal National Institutes of Health guidelines. An experi-
mental schema is presented in Figure 1. Twenty-eighte
dayeold male Fischer rats (Harlan Laboratories,
Indianapolis, IN) received sham WBI (0 Gy) or received
either 27 Gy in 9 daily fractions of 3 Gy, which is bio-
effective with 34 Gy in 1.8-Gy clinical fractions (linear-
quadratic model, a/b Z 3 Gy) (26, 27), or 34 Gy, where
the last 3-Gy fraction was replaced with a 10-Gy
boost. Animals were anesthetized with ketamine and zyla-
zine (intraperitoneally) and positioned laterally on a plat-
form shielded with a Cerrobend (Radiation Products Design,
Inc, Albertville, MN) jig exposing the cranium. Radiation
was delivered using a Gulmay RS320 x-ray unit (Gulmay
Medical, Surrey, UK) with the following parameters: 1.5-
mm copper and 3-mm aluminum filters, 300 kV at
10 mA, dose rate of 1.173 Gy/min, and focus to skin dis-
tance of 42.3 cm. To avoid radiation injury to the oral
mucosa, radiation was delivered laterally across the brain.
To account for any drop-off in radiation dose over the width
of the entire brain, the daily dose was delivered using 2
beams, 1 entering the right hemisphere and 1 entering the
left hemisphere. This was accomplished by first positioning
the animal with the right hemisphere toward the source.
After delivery of half of the daily dose, the animals were
turned over with the left hemisphere toward the source for
delivery of the second half of the daily radiation dose. Thus
any difference in dose from the point of entry of one side of
the brain to the opposite was balanced daily. This radiobi-
ological technique was used to equalize the dose across the
entire volume of the target organ. Weekly dosimetry used
Fig. 1. Experimental schema. Twenty-eightedayeold male. Fischer rats were irradiated over a period of 12 days. Baseline
studies before irradiation included magnetic resonance imaging and spectroscopy. Imaging was repeated at 3 and 6 mo after
irradiation. Behavioral testing was performed at 4 and 7 mo after irradiation.
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Products, Wayne, NJ) and a Harshaw TLD-100H (lithium
fluorideemagnesium, copper, phosphorus, (Thermo Fisher
Scientific, Waltham, MA)). calibrated dosimeter.
Magnetic resonance imaging (MRI) used a 7-Tesla field
(Bruker BioSpin, Billerica, MA; 116-mm inner diameter;
maximum gradient strength of 400 mT/m) and interfaced
with a 300-MHz resonant frequency digital spectrometer.
Signal excitation and reception used a cross-coil system
with a 7ecmeinner diameter linear birdcage and surface
coils, respectively. Animals were anesthetized with iso-
flurane and stabilized with tooth holder and ear clamps with
continuous monitoring of respiratory rate and body tem-
perature. Diffusion tensor imaging (DTI)eecho planar im-
aging data were acquired with the following parameters:
repetition time, 6250 ms; echo time, 23 ms; 1 echo; echo
spacing, 0.5 ms; flip angle, 90; bandwidth, 246,914 Hz; and
slice thickness, 0.75 mm using a nominal b value of
700. Fractional anisotropy (FA) maps were constructed
using FSL software (FMRIB Software Library v5.0, Oxford,
UK). By use of the axial slice closest to bregma 4.0, aA
Fig. 2. Fractional anisotropy (FA) of corpus callosum. (A)
diffusion tensor image with corresponding region of interest (r
defined the measureable corpus callosum. (B) Plot of mean corp
FA0) for 0 Gy (circles), 27 Gy (squares), and 34 Gy (triangles
(effect of group: F6,89 Z 5.300, PZ.0001). All animals had
continued myelination, shown by plots >1 (relative to baseline:
6-mo FA remained equivalent to 3-mo values for rats receivin
receiving 27 Gy of WBI, but declined after 34-Gy WBI (0 Gy v
figure is available at www.redjournal.org.)16  8epixel region of interest (ROI) was centered on the
identifiable corpus callosum and pixels with an FA value
>0.5 were defined for analysis (Fig. 2A). Proton magnetic
resonance spectroscopy (MRS) data were obtained from a
3  6  2emm3 voxel overlying the corpus callosum and a
3  3  3emm3 voxel overlying the right hippocampus
using 2 double spin echo point-resolved spectroscopy se-
quences, one with water suppression and one without (echo
time, 20 ms; repetition time, 2500 ms; 324 averages).
Second-order shimming was achieved using the fast, auto-
matic shimming technique by mapping along projections
(FASTMAP) technique. MRS data curve fitting and quan-
titation of metabolite levels were performed by use of
LCModel software (S. Provencher, Oakville, Ontario,
Canada), and spectra were rejected if the full width at half
maximum was >0.1 ppm or the signal-to-noise ratio was
<6dobjective measures of data quality automatically re-
ported by the processing softwaredor if a data shift along
the ppm axis was >2 SDs of the remaining scans
(0.87 < ppm shift < 0.053). Finally, outliers of the 7
predetermined metabolites defined as > or <2 SDs were1.15
1.10
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1.00
0.95
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B
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FA map of a representative coronal slice of a rat brain
ed outline) in which voxels with FA >0.5 (green outline)
us callosum FA values relative to baseline (defined as FAt/
). FA significantly increased from baseline for all groups
an increase in FA between baseline and 3 mo, indicating
0 Gy, PZ.001; 27 Gy, PZ.0001; and 34 Gy, PZ.001). The
g 0 Gy of whole-brain irradiation (WBI), as well as rats
s 34 Gy at 6 mo: PZ.01). *P<.05. (A color version of this
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total creatine (creatine þ phosphocreatine); glutamine;
glutamate; total choline (choline þ phosphocholine); total
NAA (N-acetylaspartate þ N-acetylaspartylglutamate); total
lactate (lactate þ lipids 13a þ lipids 13b); and myoinositol.
The rationale for normalizing metabolite levels to their
respective time and ROI levels was to obtain the most robust
markers. In contrast to absolute quantitation, the impact of
changes in the water content and of metabolite relaxation
times on metabolite ratios is small. To show potential dif-
ferences over development, the 3- and 6-month ratios were
further normalized to their baseline values.
The investigators were blinded with respect to treatment
group for behavioral tests, MRS, and FA measurements and
analysis. For lateralized reaction time tests, animals were
maintained on caloric restriction (85% of 3-month baseline)
beginning 2 months after WBI (28). Open field exploration
(OFE) used a circular enclosure 120 cm in diameter with 48-
cm plain white plastic walls. Animals were allowed to freely
explore the empty enclosure for 10 min/d for 2 days atTable 1 Mean (SEM) metabolite-creatine ratios
P28: Baseline
3 mo after XRT (4 mo of a
Control 27 Gy
Corpus callosum
Gln*,y 0.38 (0.06) 0.39 (0.03) 0.48 (0.02) 0
Gluz,x 1.06 (0.05) 1.20 (0.03)jj 1.21 (0.05)jj 1
tChojj,{ 0.15 (0.02) 0.15 (0.01) 0.17 (0.01) 0
NAAx,# 1.08 (0.03) 1.23 (0.02)y 1.22 (0.04)jj 1
tLac** 0.48 (0.07) 0.48 (0.05) 0.27 (0.06) 0
mIyy 0.55 (0.03) 0.55 (0.03) 0.59 (0.03) 0
Right hippocampus
Glnzz,xx 0.39 (0.05) 0.56 (0.04)jj 0.62 (0.03)jj 0
Glux,jjjj 1.12 (0.04) 1.36 (0.04)xx 1.36 (0.04)y 1
tChox,{{ 0.14 (0.01) 0.16 (0.01) 0.15 (0.01) 0
NAA## 1.11 (0.03) 1.21 (0.02) 1.18 (0.02) 1
tLac*** 0.36 (0.04) 0.37 (0.05) 0.41 (0.15) 0
mIyyy 0.55 (0.06) 0.58 (0.04) 0.55 (0.04) 0
Abbreviations: GlnZ glutamine; GluZ glutamate; mIZ myoinositol; NAA
tLac Z total lactate; XRT Z radiation therapy.
* F6,64 Z 3.131, PZ.009; post hoc t tests against baseline: 0 Gy at 6 mo,
y P<.01.
z F6,64Z 5.996, P<.0001; post hoc t tests against baseline: 0 Gy at 3 mo, P
PZ.021.
x P<.0001.
jj P<.05.
{ F6,64 Z 2.878, PZ.015; post hoc t tests against baseline: 0 Gy at 6 mo,
# F6,64Z 7.199, P<.0001; post hoc t tests against baseline: 0 Gy at 3 mo, PZ
PZ.012.
** F6,64 Z 2.028, PZ.075.
yy F6,64 Z 0.4592, PZ.836.
zz F6,69Z 5.105, PZ.0002; post hoc t tests against baseline: 0 Gy at 3 mo, P
PZ.061; Gy at 6 mo, PZ.004.
xx P<.001.
kk F6,69Z 6.762, P<.0001; post hoc t tests against baseline: 0 Gy at 3 mo, PZ
P<.0001; 27 Gy at 6 mo, PZ.0003; 34 Gy at 6 mo, PZ.0003.
{{ F6,69 Z 8.002, P<.0001; post hoc t tests against baseline: 0 Gy at 6 mo,
## F6,69 Z 0.1.780, PZ.116.
*** F6,69 Z 1.487, PZ.196.
yyy F6,69 Z 0.8460, PZ.539.4 months after WBI and for 1 day at 7 months. Total distance
and percent of time in the center were analyzed using
TopScan analysis software (CleverSys, Reston, VA) and
expressed in arbitrary units. Novel object recognition (NOR)
was tested on 2 days after OFE in the same arena (29). Two
identical objects were placed on opposite sides of the
enclosure 10 cm from the wall. On day 1, animals underwent
three 5-minute exploratory trials separated by 5-minute in-
tervals. After 24 hours, one of the objects was replaced with
a novel object, and the animal was allowed to explore for
5 minutes. The time of active exploration of each object was
measured manually with stopwatches by an observer blinded
to the treatment. A novel object preference ratio (Time
exploring novel object  Time exploring familiar object)/
(Time exploring novel object þ Time exploring familiar
object) was used for analysis. Testing with the elevated plus
maze (EPM) was performed at 4 months after WBI and not
repeated at 7 months because it relies on the novelty of the
apparatus for maximal effect. Rats were placed in the center
of a plus-shaped maze elevated 4 ft from the floor andge) 6 mo after XRT (7 mo of age)
34 Gy Control 27 Gy 34 Gy
.36 (0.04) 0.61 (0.06)y 0.43 (0.03) 0.50 (0.05)
.04 (0.03) 1.30 (0.04)x 1.15 (0.03) 1.20 (0.03)jj
.14 (0.01) 0.19 (0.01)jj 0.18 (0.01) 0.17 (0.01)
.11 (0.03) 1.31 (0.03)x 1.24 (0.02)jj 1.15 (0.03)
.43 (0.08) 0.59 (0.04) 0.43 (0.06) 0.56 (0.07)
.57 (0.04) 0.63 (0.03) 0.56 (0.03) 0.60 (0.03)
.46 (0.03)jj 0.66 (0.04)x 0.57 (0.08) 0.59 (0.04)y
.27 (0.04)jj 1.39 (0.04)x 1.40 (0.06)xx 1.34 (0.03)xx
.15 (0.01) 0.18 (0.01)xx 0.20 (0.01)x 0.17 (0.01)y
.16 (0.02) 1.17 (0.03) 1.20 (0.03) 1.13 (0.02)
.43 (0.04) 0.54 (0.06) 0.49 (0.12) 0.53 (0.06)
.53 (0.03) 0.63 (0.03) 0.63 (0.05) 0.55 (0.03)
Z N-acetylaspartate þ N-acetylaspartylglutamate; tChoZ total choline;
PZ.007.
Z.036; 27 Gy at 3 mo, PZ.42; 0 Gy at 6 mo, P<.0001; 34 Gy at 6 mo,
PZ.039.
.003; 27 Gy at 3 mo, PZ.022; 0 Gy at 6 mo, P<.0001; 27 Gy at 6 mo,
Z.014; 27 Gy at 3 mo, PZ.014; 0 Gy at 6 mo, P<.0001; 27 Gy at 6 mo,
.0002; 27 Gy at 3 mo, PZ.003; 34 Gy at 3 mo, PZ.024; 0 Gy at 6 mo,
PZ.0003; 27 Gy at 6 mo, P<.0001; 34 Gy at 6 mo, PZ.01.
Brown et al. International Journal of Radiation Oncology  Biology  Physics474allowed to freely explore for 5 minutes. Time spent in the
open arms was measured with stopwatches.
The primary outcome measure for this study was the
NOR task. Detecting an effect size of 0.25 among 3 groups
using a repeated-measures (2 time points) analysis of
variance (ANOVA) within-between interactions assuming a
correlation of 0.5 and a nonsphericity correction of 1
indicated a total group size of 42. Adding 15% for attrition
yielded a total of 48 animals, or 16 per group. Statistical
analyses were carried out using SPSS statistical software
(version 22; IBM, Armonk, NY) or Prism 6.0 (GraphPad
Software, La Jolla, CA). ANOVA was first used to analyze
all groups compared with pre-WBI values. If any F statistic
was significant to P<.05, a post hoc Student t test was
performed. Differences between baseline values were
considered significant at P<.05, adjusted for multiple
comparisons using the Dunnett test. All measurements are
reported as means  1 SEM unless otherwise specified.4.0 3.5 3.0 2.5 2.0 1.5
Frequency (ppm)
Spectrum
LCModel fit
In vivo MRS of rat brain (7T)
Tau
Cr
NAA
Glu
Lac
Ins
Cho
1.0 0.5 0.0
Fig. 3. Representative proton magnetic resonance spectra
(MRS) of corpus callosum. Abbreviations: ChoZ choline;
Cr Z creatine; Glu Z glutamate; Lac Z lactate; Ins Z
myoinositol; Tau Z taurine; NAA Z N-acetylaspartate.Results
Mean weight of animals at 28 days of age was similar for
all groups. However, irradiated animals weighed less than
sham animals by 6 months after WBI (0 Gy, 355  7 g;
27 Gy, 325  6 g; 34 Gy, 309  6 g; F2,43 Z 12.66,
P<.0001).
MRI showed no gross abnormalities up to 6 months after
WBI in all animals. At 6 months, the areas of corpus cal-
losum defined as ROIs consisting of pixels with FA values
>0.5 at bregma 4.0 were similar between 0 Gy
(1.80  0.05 mm2) and 34 Gy (1.83  0.03 mm2) (PZ.64).
The mean FA value of the corpus callosum increased in the
sham-irradiated group over time (PZ.001 at 3 months and
P<.0001 at 6 months; Fig. 2B) and this was not affected by
WBI up to the subacute phase (3 months after WBI);
however, thereafter, there was no further increase so that
mean FA in the 34-Gy group was significantly lower than
that in sham controls at 6 months (PZ.01), suggesting late
white matter injury.
The metabolite-creatine ratios measured in both the
corpus callosum and right hippocampus are presented in
Table 1. In the hippocampus, only the choline and gluta-
mate ratios increased with age, whereas in the corpus cal-
losum, most metabolite ratios did so. Figure 3 shows
representative magnetic resonance spectra obtained from
the corpus callosum. Interestingly, WBI did not affect
measures in the hippocampus, whereas there were many
changes in the corpus callosum (Fig. 4). By 6 months,
glutamine-creatine ratios had increased dramatically
with age (baseline vs 0 Gy, PZ.0066; Fig. 4A) but this
increase was not observed in either irradiated group. In
contrast, increases in glutamate, glutamine, and total NAA
(N-acetylaspartate þ N-acetylaspartylglutamate) were
delayed at 3 months after high, but not more clinically
relevant, doses of WBI. There were no significant time- or
dose-related changes in either lactate or myoinositol ratios.Given the increased prevalence of attention-deficit dis-
order in brain tumor survivors, we assessed performance of
sustained, divided attention using lateralized reaction time
tests. Unfortunately, the variance within the groups was
unexpectedly high and this resulted in no significant differ-
ences (data not shown); the test was abandoned. The results
of the other behavioral tests are presented in Table 2 and
Figure 5. In OFE assessment during the subacute period at
4 months, all groups were similarly active on day 1. How-
ever, on day 2, when sham-irradiated controls showed the
expected reduction in exploratory activity (PZ.02), animals
receiving either 27-Gy or 34-Gy WBI failed to habituate
(PZ.778 and PZ.294, respectively; Fig. 5A). By 7 months,
all groups showed a similar decrease in day 1 exploratory
behavior (P<.0001; Fig. 5B), possibly reflecting the effect of
repeated exposures to the arena in all groups. They also
showed more anxiety-like behavior in the EPM test,
spending less time in the open arms relative to controls
(PZ.002 for 27 Gy and PZ.02 for 34 Gy; Fig. 5C).
NOR was initially performed with plastic object pairs;
however, control animals failed to show a significant prefer-
ence for the novel object (F1,14Z 1.064, PZ.320), but glass
object pairs were effective (F1,14Z 23.350, P<.0001). This
subsequent exclusion of plastic object trials underpowered the
control sample size, but because the sham-irradiated controls
from the 4- and 7-month tests showed equivalent high-level
NOR, indicating no effect of time on performance (prefer-
ence ratios of 0.623 0.054 at 4-month test and 0.559 0.078
at 7months;PZ.69, t test), datawere pooled for comparisons.
At 4months, both the 27-Gy and34-Gygroups showed similar
NOR preference to controls (PZ.826 and PZ.807, respec-
tively; Fig. 5D), but by 7 months, NOR was impaired at both
doses (PZ.021 and PZ.021, respectively). An overall
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Fig. 4. (A-F) Proton magnetic resonance spectroscopy metabolite-creatine ratios from corpus callosum plotted relative to
baseline values for animals receiving 0 Gy (circles), 27 Gy (squares), and 34 Gy (triangles). *P<.05, **P<.01, ***P<.001,
****P<.0001.
Volume 96  Number 2  2016 Brain irradiation in juvenile rat 475ANOVA with the pooled sham controls and the 2 irradiated
groups for the 4- and 7-month time points indicated an overall
main effect (F4,42 Z 2.670, PZ.047). We explored theTable 2 Results of behavioral tests
0 Gy
Open field
4 mo, day 1
Distance units  SEM (n)* 7234  368 (15)
% of time in center  SEM (n)y 8.223  1.336 (15)
4 mo, day 2,z
distance units  SEM (n)
6125  427 (15)x
7 mo, day 1,jj,{
distance units  SEM (n)
5934  462 (12)
Elevated plus maze (4 mo),#,**
% of time in open arm  SEM (n)
16.4  2.8 (15)
Novel object recognition, preference ratio  SEM (n)
4 mo 0.572  0.062 (14)yy
7 mox,zz 0.572  0.062 (14)yy
* Analysis of variance (ANOVA): F2,45 Z 0.619, PZ.54.
y ANOVA: F2,45 Z 0.150, PZ.86.
z Repeated-measures ANOVA within each group between day 1 and day 2
F1,16 Z 0.083, PZ.29.
x P<.05.
jj Two-way ANOVA of day 1 exploration distances at both 4 mo and 7 mo b
F2,81 Z 1.037, PZ.36; interaction: F2,81 Z 0.0221, PZ.98.
{ P<.0001.
# ANOVAdeffect of group: F2,45 Z 5.557, P<.007 (LSD post hoc t tests r
** P<.01.
yy Zero-gray novel object recognition tests were combined for analysis to incre
4 mo (0.623  0.054, nZ3) and 7 mo (0.559  0.078, nZ11); t test of mean
zz ANOVA comparing 27 Gy and 34 Gy at each time point with pooled 0-G
relative to pooled 0 Gy: PZ.02 for 27 Gy at 6 mo and PZ.02 for 34 Gy at 6possibility that we failed to detect a difference at the 4-month
time point because of a lack of power associated with the
smaller sample size. The power required to detect a difference27 Gy 34 Gy
7865  379 (16) 7431  453 (17)
9.094  1.756 (16) 8.067  1.168 (17)
7714  469 (16) 6740  414 (17)
6423  424 (15) 5966  314 (13)
7.8  1.0 (15)** 10.75  1.3 (16)x
0.636  0.124 (4) 0.508  0.134 (5)
0.066  0.228 (10)x 0.053  0.221 (9)x
: 0 Gy, F1,13 Z 7.036, PZ.02; 27 Gy, F1,15 Z 0.083, PZ.78; 34 Gy,
etween groupsdeffect of time: F1,81 Z 17.09, P<.0001; effect of dose:
elative to 0 Gy: PZ.002 for 27 Gy and PZ.04 for 34 Gy).
ase power to evaluate for overall effect: 0-Gy preference ratios  SEM at
s between time points, PZ.69.
y valuesdeffect of group: F4,37 Z 2.679, PZ.05 (LSD post hoc t tests
mo).
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Fig. 5. Behavioral testing. (A) The total distances moved in open field exploration by sham and whole-brain irradiation
(WBI) rats on day 1 (solid bars) were equivalent (effect of group: F2,46Z 0.591, PZ.558). A repeated-measures analysis of
variance within each group was used to assess exploratory habituation on the second open field exposure (checkered bars).
The control animals (0 Gy) showed a significant reduction in exploratory activity on day 2 relative to day 1 (F1,13Z 7.036,
PZ.02) unlike both WBI groups (27 Gy: F1,15 Z 0.083, PZ.778; 34 Gy: F1,16 Z 0.083, PZ.294). (B) Day 1 exploratory
behavior was similar among groups at 4 mo (solid bars) and 7 mo (striped bars) but significantly decreased, indicating some
retained familiarity with the arena (two-way analysis of variance on effect of time: F1,81 Z 17.09, P<.0001). (C) The
elevated plus maze showed significant decreases in time spent in the open arms by both WBI groups (overall effect of group:
F2,45 Z 5.557, PZ.007; Least significant difference (LSD) planned post hoc comparisons relative to sham: PZ.002 for
27 Gy and PZ.04 for 34 Gy). (D) On the 24-h novel object recognition task, animals receiving 27 Gy (squares) and animals
receiving 34 Gy (triangles) showed an overall main effect (F4,42 Z 2.670, PZ.047) when compared with pooled sham-
irradiated controls (circles). Both the 27-Gy and 34-Gy groups showed normal novel object preference at 4 mo (PZ.826
and PZ.807, respectively) but impairment at 7 mo (PZ.02 and PZ.02, respectively). *P<.05, **P<.01, ***P<.001,
****P<.0001
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effect sizes of 1.1 for 27 Gy and 1.2 for 34 Gy) was estimated
by a post hoc power calculation with the lowest sample size
(ie, 20). A 1-way ANOVAwith NZ20 divided into 5 groups
has a power of 0.88 to detect an effect of 1 with an a error of
.05. Although these data do not exclude some degree of NOR
impairment at 4months, one as large as that seen at 7months is
highly unlikely.Discussion
We report imaging and cognitive effects of WBI in the
developing brains of juvenile rats during the subacute and
late periods after WBI using a clinically relevant dose and ahigher dose of fractionated irradiation. FA levels in the
corpus callosum of sham-irradiated rats increased over the
study period, consistent with normal white matter devel-
opment, and WBI did not affect this up to at least 3 months.
However, the later increase was blunted after high-dose
WBI (34 Gy). In children and adults who survive radiation
therapy for brain cancer, decreases in FA in white matter
have been reported (30, 31). In rats, other authors have
variably shown a decrease in FA in the corpus callosum
1 year after large single WBI doses (32) or no change after
fractionated irradiation with larger bioequivalent doses than
we used (33, 34). Further work is needed using clinically
relevant doses at later time points and including other
diffusion tensor imaging parameters, such as mean diffu-
sivity, and areas other than the corpus callosum, such as the
Volume 96  Number 2  2016 Brain irradiation in juvenile rat 477fimbria, that have been implicated in hippocampal impair-
ment (35) before the value of MRI in imaging white matter
changes can be fully evaluated.
MRS, on the other hand, has been shown to demonstrate
metabolic alterations associated with brain injury before
structural changes have emerged (36). We investigated
changes in the metabolic profiles in both the hippocampus
and corpus callosum of juvenile rats after WBI. The hip-
pocampus showed no changes that could be attributed to
irradiation, which is consistent with the findings of Robbins
et al (37) in adult rats. In contrast, the corpus callosum
showed significant WBI-associated alterations in metabolic
profiles. Developmental changes were observed with most
metabolites that were either delayed or completely pre-
vented by high-dose WBI. Most noteworthy was the
blunting of the increase in the glutamine ratios late after
both clinically relevant and high radiation dosesdthe time
when NOR is impaired. Glutamine, the most abundant
amino acid in the cerebrospinal fluid, is synthesized by
astrocytes and is generally reported in combination
with glutamate because of their interdependency in
neuronal-glial interactions. In contrast, glutamate is pri-
marily synthesized by neurons and metabolized to
glutamine by astrocytes (38). Disruption of glutamine
synthesis has been associated with viral-induced astrocytic
gliosis that may lead to neuronal dysfunction and may serve
as a marker of clinically significant injury (39).
Prefrontal lobe dysfunction after WBI is suggested by
reports of an increased incidence of attention-deficit dis-
order and impairment in both executive function and
working memory after childhood radiation therapy for
cancer (40, 41). Because this can impair school learning, it
has been postulated that addressing prefrontal dysfunction
may improve overall outcome and radiation-induced loss in
IQ (42, 43). Our study showed that both WBI doses caused
decreased exploratory behavior in the EPM test and pre-
vented habituation in OFE at 4 months by rats, which is
suggestive of early-onset prefrontal dysfunction. NOR, on
the other hand, is most often used to measure hippocampal-
independent working memory; however, in our test, with a
24-hour interval, it is hippocampal dependent (44). Our
demonstration that NOR is not affected 4 months after WBI
but is dramatically impaired at the late time point may be
the first demonstration of hippocampal-dependent declara-
tive non-spatial memory deficit following clinically rele-
vant fractionated juvenile WBI. Several studies have shown
impairment in this task using short intersession delays, but
these more likely reflect prefrontal dysfunction than long-
term memory impairment (37, 45-48). A limitation of our
observation that NOR is normal at 4 months after WBI is
the small number of animals, as described in the Results
section. However, a post hoc power calculation indicated
that any difference in the subacute phase is likely to be
much less than that observed in the late phase. Throughout,
our studies point to the conclusion that subacute deficits in
the developing brain after WBI are markedly less than
those during the late phase, which is perhaps surprising.In summary, we report imaging and behavioral outcomes
of clinically relevant fractionated WBI in the prepubescent
male rat that are consistent with observations in survivors
of pediatric cancer treated in a similar manner. We further
show that prefrontal dysfunction may antecede long-term
memory impairment but may not necessarily be related to
long-term cognitive dysfunction. The finding that WBI in-
terferes with the normal increase of glutamine concentra-
tion in the corpus callosum suggests that injury to this
structure may contribute to defects in hippocampal-
dependent declarative memory, as has been suggested in
the cortical-hippocampal system (49). Finally, these ob-
servations may serve as a suitable preclinical platform to
link clinically relevant outcomes and histologic pathogen-
esis, as well as to evaluate radiation mitigation strategies.
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